Literature DB >> 21979464

TRAP1 and the proteasome regulatory particle TBP7/Rpt3 interact in the endoplasmic reticulum and control cellular ubiquitination of specific mitochondrial proteins.

M R Amoroso1, D S Matassa, G Laudiero, A V Egorova, R S Polishchuk, F Maddalena, A Piscazzi, S Paladino, D Sarnataro, C Garbi, M Landriscina, F Esposito.   

Abstract

Tumor necrosis factor receptor-associated protein-1 (TRAP1) is a mitochondrial (MITO) antiapoptotic heat-shock protein. The information available on the TRAP1 pathway describes just a few well-characterized functions of this protein in mitochondria. However, our group's use of mass-spectrometric analysis identified TBP7, an AAA-ATPase of the 19S proteasomal subunit, as a putative TRAP1-interacting protein. Surprisingly, TRAP1 and TBP7 colocalize in the endoplasmic reticulum (ER), as demonstrated by biochemical and confocal/electron microscopic analyses, and interact directly, as confirmed by fluorescence resonance energy transfer analysis. This is the first demonstration of TRAP1's presence in this cellular compartment. TRAP1 silencing by short-hairpin RNAs, in cells exposed to thapsigargin-induced ER stress, correlates with upregulation of BiP/Grp78, thus suggesting a role of TRAP1 in the refolding of damaged proteins and in ER stress protection. Consistently, TRAP1 and/or TBP7 interference enhanced stress-induced cell death and increased intracellular protein ubiquitination. These experiments led us to hypothesize an involvement of TRAP1 in protein quality control for mistargeted/misfolded mitochondria-destined proteins, through interaction with the regulatory proteasome protein TBP7. Remarkably, expression of specific MITO proteins decreased upon TRAP1 interference as a consequence of increased ubiquitination. The proposed TRAP1 network has an impact in vivo, as it is conserved in human colorectal cancers, is controlled by ER-localized TRAP1 interacting with TBP7 and provides a novel model of the ER-mitochondria crosstalk.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21979464      PMCID: PMC3307973          DOI: 10.1038/cdd.2011.128

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  37 in total

Review 1.  Imaging fluorescence resonance energy transfer as probe of membrane organization and molecular associations of GPI-anchored proteins.

Authors:  A K Kenworthy; M Edidin
Journal:  Methods Mol Biol       Date:  1999

2.  Altered transcriptional regulation in cells expressing the expanded polyglutamine androgen receptor.

Authors:  Andrew P Lieberman; George Harmison; Andrew D Strand; James M Olson; Kenneth H Fischbeck
Journal:  Hum Mol Genet       Date:  2002-08-15       Impact factor: 6.150

3.  Mitochondrial chaperone Trap1 and the calcium binding protein Sorcin interact and protect cells against apoptosis induced by antiblastic agents.

Authors:  Matteo Landriscina; Gabriella Laudiero; Francesca Maddalena; Maria Rosaria Amoroso; Annamaria Piscazzi; Flora Cozzolino; Maria Monti; Corrado Garbi; Alberto Fersini; Piero Pucci; Franca Esposito
Journal:  Cancer Res       Date:  2010-07-20       Impact factor: 12.701

4.  Exploiting the mitochondrial unfolded protein response for cancer therapy in mice and human cells.

Authors:  Markus D Siegelin; Takehiko Dohi; Christopher M Raskett; Gregory M Orlowski; Christine M Powers; Candace A Gilbert; Alonzo H Ross; Janet Plescia; Dario C Altieri
Journal:  J Clin Invest       Date:  2011-04       Impact factor: 14.808

5.  Functional interplay between mitochondrial and proteasome activity in skin aging.

Authors:  Rafał Kozieł; Ruth Greussing; Andrea B Maier; Lieve Declercq; Pidder Jansen-Dürr
Journal:  J Invest Dermatol       Date:  2010-12-30       Impact factor: 8.551

6.  The Unfolded Protein Response, Degradation from Endoplasmic Reticulum and Cancer.

Authors:  Yien Che Tsai; Allan M Weissman
Journal:  Genes Cancer       Date:  2010-07-01

Review 7.  Heat shock proteins, cell survival and drug resistance: the mitochondrial chaperone TRAP1, a potential novel target for ovarian cancer therapy.

Authors:  Matteo Landriscina; Maria Rosaria Amoroso; Annamaria Piscazzi; Franca Esposito
Journal:  Gynecol Oncol       Date:  2009-11-25       Impact factor: 5.482

8.  AROS-29 is involved in adaptive response to oxidative stress.

Authors:  Nicola Montesano Gesualdi; Giuseppa Chirico; Maria Teresa Catanese; Giuseppe Pirozzi; Franca Esposito
Journal:  Free Radic Res       Date:  2006-05

9.  The ER-resident ubiquitin-specific protease 19 participates in the UPR and rescues ERAD substrates.

Authors:  Gerco C Hassink; Bin Zhao; Ramakrishna Sompallae; Mikael Altun; Stefano Gastaldello; Nikolay V Zinin; Maria G Masucci; Kristina Lindsten
Journal:  EMBO Rep       Date:  2009-05-22       Impact factor: 8.807

10.  Targeted inhibition of mitochondrial Hsp90 suppresses localised and metastatic prostate cancer growth in a genetic mouse model of disease.

Authors:  B H Kang; M Tavecchio; H L Goel; C-C Hsieh; D S Garlick; C M Raskett; J B Lian; G S Stein; L R Languino; D C Altieri
Journal:  Br J Cancer       Date:  2011-02-01       Impact factor: 7.640

View more
  38 in total

1.  Genetic Regulation of Neuronal Progranulin Reveals a Critical Role for the Autophagy-Lysosome Pathway.

Authors:  Lisa P Elia; Amanda R Mason; Amela Alijagic; Steven Finkbeiner
Journal:  J Neurosci       Date:  2019-01-29       Impact factor: 6.167

2.  New insights into TRAP1 pathway.

Authors:  Danilo Swann Matassa; Maria Rosaria Amoroso; Francesca Maddalena; Matteo Landriscina; Franca Esposito
Journal:  Am J Cancer Res       Date:  2012-02-19       Impact factor: 6.166

3.  Proteomic Analysis of Salmonella-modified Membranes Reveals Adaptations to Macrophage Hosts.

Authors:  Tatjana Reuter; Stephanie Vorwerk; Viktoria Liss; Tzu-Chiao Chao; Michael Hensel; Nicole Hansmeier
Journal:  Mol Cell Proteomics       Date:  2020-02-26       Impact factor: 5.911

4.  Downregulation of TRAP1 aggravates injury of H9c2 cardiomyocytes in a hyperglycemic state.

Authors:  Xiaodan Zhang; Zhen Zhong; Wangen Li
Journal:  Exp Ther Med       Date:  2019-08-05       Impact factor: 2.447

5.  Gene Copy Number and Post-Transductional Mechanisms Regulate TRAP1 Expression in Human Colorectal Carcinomas.

Authors:  Michele Pietrafesa; Francesca Maddalena; Luciana Possidente; Valentina Condelli; Pietro Zoppoli; Valeria Li Bergolis; Maria Grazia Rodriquenz; Michele Aieta; Giulia Vita; Franca Esposito; Matteo Landriscina
Journal:  Int J Mol Sci       Date:  2019-12-24       Impact factor: 5.923

6.  Expression of tumor necrosis factor receptor-associated protein 1 and its clinical significance in kidney cancer.

Authors:  Tong Si; Guosheng Yang; Xiaofu Qiu; Youhua Luo; Baichuan Liu; Bingwei Wang
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

7.  Heat shock proteins in cancer stem cell maintenance: A potential therapeutic target?

Authors:  Giacomo Lettini; Silvia Lepore; Fabiana Crispo; Lorenza Sisinni; Franca Esposito; Matteo Landriscina
Journal:  Histol Histopathol       Date:  2019-07-19       Impact factor: 2.303

8.  TRAP1 regulates stemness through Wnt/β-catenin pathway in human colorectal carcinoma.

Authors:  Giacomo Lettini; Lorenza Sisinni; Valentina Condelli; Danilo Swann Matassa; Vittorio Simeon; Francesca Maddalena; Marica Gemei; Elvira Lopes; Giulia Vita; Luigi Del Vecchio; Franca Esposito; Matteo Landriscina
Journal:  Cell Death Differ       Date:  2016-09-23       Impact factor: 15.828

Review 9.  Modulation of Molecular Chaperones in Huntington's Disease and Other Polyglutamine Disorders.

Authors:  Sara D Reis; Brígida R Pinho; Jorge M A Oliveira
Journal:  Mol Neurobiol       Date:  2016-09-22       Impact factor: 5.590

10.  TRAP1-dependent regulation of p70S6K is involved in the attenuation of protein synthesis and cell migration: relevance in human colorectal tumors.

Authors:  Danilo Swann Matassa; Ilenia Agliarulo; Maria Rosaria Amoroso; Francesca Maddalena; Leandra Sepe; Maria Carla Ferrari; Vinay Sagar; Silvia D'Amico; Fabrizio Loreni; Giovanni Paolella; Matteo Landriscina; Franca Esposito
Journal:  Mol Oncol       Date:  2014-06-13       Impact factor: 6.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.